BIO-TECHNE Corp - COMMON STOCK (TECH)

Historical Holders from Q3 2014 to Q3 2025

Symbol
TECH on Nasdaq
CUSIP
09073M104
Type / Class
Equity / COMMON STOCK
Shares outstanding
152M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
159M
Holdings value
$8.84B
% of all portfolios
0.012%
Grand Portfolio weight change
+0%
Number of holders
561
Number of buys
302
Number of sells
-250
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $567M 11M BlackRock, Inc. Jun 30, 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -56.7% $186M -$306M 3.35M -62.1% T. Rowe Price Associates, Inc. Sep 30, 2025

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 159M $8.84B +$43.8M $55.63 561
2025 Q2 159M $8.16B -$119M $51.45 549
2025 Q1 160M $9.4B +$179M $58.63 566
2024 Q4 157M $11.3B +$202M $72.03 564
2024 Q3 153M $12.2B -$146M $79.93 554
2024 Q2 156M $11.2B -$58.2M $71.65 564
2024 Q1 157M $11B +$73.3M $70.39 541
2023 Q4 156M $12B +$408M $77.16 522
2023 Q3 150M $10.2B -$104M $68.07 518
2023 Q2 151M $12.3B +$213M $81.63 516
2023 Q1 149M $11B -$127M $74.19 536
2022 Q4 150M $12.4B +$9.21B $82.88 531
2022 Q3 38M $10.8B +$194M $284.00 514
2022 Q2 37.2M $12.9B -$179M $346.64 530
2022 Q1 37.7M $16.3B +$325M $433.04 545
2021 Q4 36.9M $19.1B -$21.7M $517.34 559
2021 Q3 36.7M $17.8B +$72M $484.57 555
2021 Q2 36.6M $16.5B +$204M $450.26 504
2021 Q1 36.5M $13.9B +$173M $381.93 461
2020 Q4 36.2M $11.5B -$13.8M $317.55 424
2020 Q3 36.2M $8.98B -$42.8M $247.73 408
2020 Q2 36.4M $9.6B -$81.5M $264.07 381
2020 Q1 36.8M $6.99B +$119M $189.62 354
2019 Q4 35.8M $7.85B -$46M $219.51 363
2019 Q3 36M $7.04B +$117M $195.67 331
2019 Q2 35.4M $7.38B +$62M $208.49 360
2019 Q1 35.5M $7.05B +$61.4M $198.55 347
2018 Q4 35.4M $5.12B -$123M $144.72 316
2018 Q3 35.8M $7.31B +$15.7M $204.11 337
2018 Q2 36M $5.33B +$35.4M $147.95 333
2018 Q1 35.9M $5.42B -$28.5M $151.04 327
2017 Q4 36.4M $4.71B -$46.7M $129.55 289
2017 Q3 36.9M $4.46B -$52.5M $120.89 284
2017 Q2 37.3M $4.38B +$215M $117.50 273
2017 Q1 36.5M $3.71B +$392M $101.65 266
2016 Q4 35.9M $3.7B +$12.7M $102.83 270
2016 Q3 35.8M $3.92B -$133M $109.50 279
2016 Q2 37.1M $4.18B -$54.3M $112.77 278
2016 Q1 37.4M $3.53B +$19.9M $94.52 251
2015 Q4 37.4M $3.36B +$85.9M $90.00 258
2015 Q3 36.3M $3.36B -$28.6M $92.46 245
2015 Q2 36.7M $3.62B +$4.88M $98.47 238
2015 Q1 36.5M $3.66B +$73.8M $100.29 242
2014 Q4 36.1M $3.33B +$2.87B $92.40 252
2014 Q3 4.95M $463M +$463M $93.55 24